Holis, Renata Vesela
Garcia, Beate Hennie
Lehnbom, Elin Christina
Fagerli, Marie
Majeed, Ashrak
Johnsgård, Tine
Zahl-Holmstad, Birgitte
Svendsen, Kristian
Ofstad, Eirik Hugaas
Risør, Torsten
Walter, Scott R.
Waaseth, Marit
Skjold, Frode
Elenjord, Renate
Funding for this research was provided by:
Helse Nord RHF (HNF1483-19)
Article History
Received: 26 November 2024
Accepted: 21 March 2025
First Online: 12 April 2025
Declarations
:
: The study received approval from the Data Protection Officer at the Hospital Pharmacy of North Norway Trust (letter dated November 28, 2019) who has the project responsibility, as well as from the three participating hospitals; Data Protection Officers at University Hospital of North Norway Trust in Tromsø and in Harstad (No. 02330), and Data Protection Officer at Nordland Hospital Trust in Bodø (No. 28 − 19). These entities serve as the ethical representatives for studies that fall outside the jurisdictions of the Regional Committees for Medical and Health Research Ethics in Norway. This particular study was deemed outside their jurisdiction because it did not involve the collection of patient-sensitive information. The study was conducted in compliance with the protocol, the principles of Good Clinical Practice, and the Declaration of Helsinki []. Written informed consent was obtained from the nurses before initiating any observations. Patients and collaborating healthcare personnel were informed about the ongoing study and the observer’s role, both verbally by the observer and through written information.
: Not applicable.
: The authors declare no competing interests.